MacroGenics (MGNX) PT Lowered to $6 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
MacroGenics (MGNX) PT Lowered to $5 at BMO Capital
August 7, 2024 9:23 AM EDTBMO Capital analyst Etzer Darout lowered the price target on MacroGenics (NASDAQ: MGNX) to $5.00 (from $8.00) while maintaining a Market Perform rating.
The analyst commented, "MGNX's 2Q update was in line with our expectations following the vobra duo (BH3 ADC) news last... More
Macrogenics (MGNX) Misses Q2 EPS by 23c
August 6, 2024 4:52 PM EDTMacrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
... More